State Street Corp Greenwich Life Sciences, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, State Street Corp holds 13,002 shares of GLSI stock, worth $224,414. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,002
Previous 13,002
-0.0%
Holding current value
$224,414
Previous $136,000
90.44%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding GLSI
# of Institutions
31Shares Held
645KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA223KShares$3.85 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny63.8KShares$1.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA58.2KShares$1.01 Million0.0% of portfolio
-
Black Rock Inc. New York, NY56.5KShares$974,4820.0% of portfolio
-
Goldman Sachs Group Inc New York, NY41.5KShares$716,3760.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $222M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...